These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 8680268)

  • 1. Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries.
    Willerson JT; Igo SR; Yao SK; Ober JC; Macris MP; Ferguson JJ
    Tex Heart Inst J; 1996; 23(1):1-8. PubMed ID: 8680268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries.
    Yao SK; Ober JC; Krishnaswami A; Ferguson JJ; Anderson HV; Golino P; Buja LM; Willerson JT
    Circulation; 1992 Oct; 86(4):1302-9. PubMed ID: 1394936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposome-bound prostaglandin E1 often prevents cyclic flow variations in stenosed and endothelium-injured canine coronary arteries.
    Willerson JT; Yao SK; McNatt J; Cui K; Anderson HV; Swensen C; Ostro M; Buja LM
    Circulation; 1994 Apr; 89(4):1786-91. PubMed ID: 8149544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
    Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM
    Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by nitroglycerin of canine platelet aggregation and cyclic flow reductions in stenosed coronary arteries.
    Tanaka T; Morishima Y; Watanabe K; Takahashi M; Shibano T
    Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):693-700. PubMed ID: 9053590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined ADP and thromboxane A2 antagonism prevents cyclic flow variations in stenosed and endothelium-injured arteries in nonhuman primates.
    Yao SK; McNatt J; Cui K; Anderson HV; Maffrand JP; Buja LM; Willerson JT
    Circulation; 1993 Dec; 88(6):2888-93. PubMed ID: 8252702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active oxygen species play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries.
    Yao SK; Ober JC; Gonenne A; Clubb FJ; Krishnaswami A; Ferguson JJ; Anderson HV; Gorecki M; Buja LM; Willerson JT
    Circ Res; 1993 Nov; 73(5):952-67. PubMed ID: 8403265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of nitric oxide to coronary vasodilation during hypercapnic acidosis.
    Gurevicius J; Salem MR; Metwally AA; Silver JM; Crystal GJ
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H39-47. PubMed ID: 7530920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free oxygen radicals contribute to platelet aggregation and cyclic flow variations in stenosed and endothelium-injured canine coronary arteries.
    Ikeda H; Koga Y; Oda T; Kuwano K; Nakayama H; Ueno T; Toshima H; Michael LH; Entman ML
    J Am Coll Cardiol; 1994 Dec; 24(7):1749-56. PubMed ID: 7963124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis.
    Shiode N; Morishima N; Nakayama K; Yamagata T; Matsuura H; Kajiyama G
    J Am Coll Cardiol; 1996 Feb; 27(2):304-10. PubMed ID: 8557898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abolition of cyclic flow variations in stenosed, endothelium-injured coronary arteries in nonhuman primates with a peptide fragment (VCL) derived from human plasma von Willebrand factor-glycoprotein Ib binding domain.
    McGhie AI; McNatt J; Ezov N; Cui K; Mower LK; Hagay Y; Buja LM; Garfinkel LI; Gorecki M; Willerson JT
    Circulation; 1994 Dec; 90(6):2976-81. PubMed ID: 7994845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of calcium channel blockade to reduce platelet-mediated cyclic flow variations in dogs with coronary stenosis and endothelial injury.
    Beaughard M; Brasset M; John G; Massingham R
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):577-83. PubMed ID: 8569218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium nitroprusside, an endothelium-derived relaxing factor congener, increases platelet cyclic GMP levels and inhibits epinephrine-exacerbated in vivo platelet thrombus formation in stenosed canine coronary arteries.
    Rovin JD; Stamler JS; Loscalzo J; Folts JD
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):626-31. PubMed ID: 7505366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraplatelet tetrahydrobiopterin plays an important role in regulating canine coronary arterial thrombosis by modulating intraplatelet nitric oxide and superoxide generation.
    Kanaya S; Ikeda H; Haramaki N; Murohara T; Imaizumi T
    Circulation; 2001 Nov; 104(20):2478-84. PubMed ID: 11705828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous and exogenous nitric oxide protect against intracoronary thrombosis and reocclusion after thrombolysis.
    Yao SK; Akhtar S; Scott-Burden T; Ober JC; Golino P; Buja LM; Casscells W; Willerson JT
    Circulation; 1995 Aug; 92(4):1005-10. PubMed ID: 7641335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans.
    Lefroy DC; Crake T; Uren NG; Davies GJ; Maseri A
    Circulation; 1993 Jul; 88(1):43-54. PubMed ID: 8319355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries.
    Bush LR; Campbell WB; Buja LM; Tilton GD; Willerson JT
    Circulation; 1984 Jun; 69(6):1161-70. PubMed ID: 6546902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of vascular tissue to the antiplatelet activity of sodium nitroprusside.
    Booth BP; Fung HL
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):129-33. PubMed ID: 9676732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries.
    Bush LR; Campbell WB; Kern K; Tilton GD; Apprill P; Ashton J; Schmitz J; Buja LM; Willerson JT
    Circ Res; 1984 Nov; 55(5):642-52. PubMed ID: 6488486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypomagnesemia inhibits nitric oxide release from coronary endothelium: protective role of magnesium infusion after cardiac operations.
    Pearson PJ; Evora PR; Seccombe JF; Schaff HV
    Ann Thorac Surg; 1998 Apr; 65(4):967-72. PubMed ID: 9564911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.